
Keywords: ADP; adenosine diphosphate; CD40L; CD40 ligand; EDTA; ethylenediaminetetraacetic acid; GPIIbIIIa; glycoprotein IIb-IIIa; PD; pharmacodynamics; PK; pharmacokinetics; RBCs; red blood cells; SCD; sickle cell disease; SD; standard deviation; TF; tissue factor